Litcius/Paper detail

Prosaposin mediates inflammation in atherosclerosis

Mandy M. T. van Leent, Thijs J. Beldman, Yohana C. Toner, Marnix Lameijer, Nils Rother, Siroon Bekkering, Abraham J. P. Teunissen, Xianxiao Zhou, Roy van der Meel, Joost Malkus, Sheqouia A. Nauta, Emma D. Klein, François Fay, Brenda L. Sánchez-Gaytán, Carlos Pérez‐Medina, Ewelina Kluza, Yuxiang Ye, Gregory R. Wojtkiewicz, Edward A. Fisher, Filip K. Świrski, Matthias Nahrendorf, Bin Zhang, Yang Li, Bowen Zhang, Leo A. B. Joosten, Gerard Pasterkamp, Arjan Boltjes, Zahi A. Fayad, Esther Lutgens, Mihai G. Netea, Niels P. Riksen, Willem J. M. Mulder, Raphaël Duivenvoorden

2021Science Translational Medicine102 citationsDOIOpen Access PDF

Abstract

expression and inflammation in human carotid atherosclerotic plaques. Our findings provide mechanistic insights into the development of atherosclerosis and identify prosaposin as a potential therapeutic target.

Topics & Concepts

InflammationPI3K/AKT/mTOR pathwayApolipoprotein EP70-S6 Kinase 1BiologyCell biologySignal transductionCancer researchRegulatorImmunologyMedicineGeneInternal medicineBiochemistryDiseaseLysosomal Storage Disorders ResearchSphingolipid Metabolism and SignalingCellular transport and secretion
Prosaposin mediates inflammation in atherosclerosis | Litcius